• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Blepharokeratoconjunctivitis in childhood: corneal involvement and visual outcome.儿童睑角膜结膜炎:角膜受累情况及视力预后
Eye (Lond). 2016 Mar;30(3):438-46. doi: 10.1038/eye.2015.249. Epub 2015 Dec 4.
2
Visual outcome and corneal changes in children with chronic blepharokeratoconjunctivitis.慢性睑角膜结膜炎患儿的视力预后及角膜变化
Ophthalmology. 2007 Dec;114(12):2271-80. doi: 10.1016/j.ophtha.2007.01.021.
3
Long-term visual outcome of childhood blepharokeratoconjunctivitis.儿童睑缘角结膜炎的长期视觉预后
Am J Ophthalmol. 2007 Mar;143(3):528-9. doi: 10.1016/j.ajo.2006.09.058. Epub 2006 Nov 9.
4
Clinical spectrum of pediatric blepharokeratoconjunctivitis.小儿睑缘角膜结膜炎的临床谱
J AAPOS. 2010 Dec;14(6):527-9. doi: 10.1016/j.jaapos.2010.09.013. Epub 2010 Nov 19.
5
Augmentin duo™ in the treatment of childhood blepharokeratoconjunctivitis.奥格门汀复方制剂™治疗儿童睑缘角结膜炎。
J Pediatr Ophthalmol Strabismus. 2010 Nov-Dec;47(6):356-60. doi: 10.3928/01913913-20100118-01. Epub 2010 Jan 22.
6
Rise in the incidence of severe pediatric blepharokeratoconjunctivitis during the COVID-19 pandemic.新冠疫情期间儿童重度眼睑-角结膜炎发病率上升。
J AAPOS. 2023 Aug;27(4):216-219. doi: 10.1016/j.jaapos.2023.05.003. Epub 2023 Jun 24.
7
[Clinical manifestations of 172 patients with blepharokeratoconjunctivitis].172例睑缘角结膜炎患者的临床表现
Zhonghua Yan Ke Za Zhi. 2016 Mar;52(3):174-9. doi: 10.3760/cma.j.issn.0412-4081.2016.03.006.
8
Sub-tenon triamcinolone acetonide injections for topical medication intolerance in chronic blepharokeratoconjunctivitis.经颞浅部曲安奈德注射治疗慢性眼睑边缘性角膜炎-结膜炎局部用药不耐受。
Cornea. 2014 Sep;33(9):999-1001. doi: 10.1097/ICO.0000000000000200.
9
Management of inflammatory corneal melt leading to central perforation in children: a retrospective study and review of literature.儿童炎症性角膜融解导致中央穿孔的治疗:一项回顾性研究及文献综述
Eye (Lond). 2016 Apr;30(4):593-601. doi: 10.1038/eye.2015.278. Epub 2016 Jan 29.
10
Severity of pediatric blepharokeratoconjunctivitis in Asian eyes.亚洲人儿童眼脸-角膜-结膜炎的严重程度。
Am J Ophthalmol. 2012 Mar;153(3):564-570.e1. doi: 10.1016/j.ajo.2011.08.037. Epub 2011 Nov 8.

引用本文的文献

1
Pediatric blepharokeratoconjunctivitis: findings and outcomes in Hispanic vs. Non-Hispanic patients.小儿睑缘角膜结膜炎:西班牙裔与非西班牙裔患者的研究结果与预后
BMC Ophthalmol. 2025 Apr 15;25(1):210. doi: 10.1186/s12886-025-04054-3.
2
Clinical manifestation and management of severe blepharokeratoconjunctivitis combined with corneal perforation.重度睑角膜结膜炎合并角膜穿孔的临床表现与处理
Int J Ophthalmol. 2025 Feb 18;18(2):229-236. doi: 10.18240/ijo.2025.02.05. eCollection 2025.
3
Ocular Rosacea: An Updated Review.眼部酒渣鼻:最新综述
Cornea. 2025 Apr 1;44(4):525-537. doi: 10.1097/ICO.0000000000003785. Epub 2025 Jan 14.
4
The visual impact of higher-order aberrations in patients with pediatric blepharokeratoconjunctivitis.小儿睑板腺角膜结膜炎患者高阶像差的视觉影响。
Int Ophthalmol. 2024 Feb 12;44(1):60. doi: 10.1007/s10792-024-03002-2.
5
Definition and Diagnostic Criteria for Pediatric Blepharokeratoconjunctivitis.儿童睑裂部角膜结膜炎的定义和诊断标准。
JAMA Ophthalmol. 2024 Jan 1;142(1):39-47. doi: 10.1001/jamaophthalmol.2023.5750.
6
Proteomic Analysis of Meibomian Gland Secretions in Patients With Blepharokeratoconjunctivitis.睑板腺功能障碍性角结膜炎患者的睑板腺分泌物的蛋白质组学分析。
Transl Vis Sci Technol. 2022 Dec 1;11(12):4. doi: 10.1167/tvst.11.12.4.
7
Safety and Feasibility of Low Fluence Intense Pulsed Light for Treating Pediatric Patients with Moderate-to-Severe Blepharitis.低能量强脉冲光治疗中重度睑缘炎患儿的安全性和可行性
J Clin Med. 2022 May 30;11(11):3080. doi: 10.3390/jcm11113080.
8
Topical Steroids and Antibiotics for Adult Blepharokeratoconjunctivitis (BKC): A Meta-Analysis of Randomized Clinical Trials.成人睑缘角结膜炎(BKC)的局部用类固醇和抗生素:随机临床试验的荟萃分析
J Ophthalmol. 2021 Jan 8;2021:3467620. doi: 10.1155/2021/3467620. eCollection 2021.
9
Evaluation of the ocular surface characteristics and Demodex infestation in paediatric and adult blepharokeratoconjunctivitis.儿童和成人睑缘角结膜炎患者眼表特征及蠕形螨感染情况的评估
BMC Ophthalmol. 2019 Mar 7;19(1):67. doi: 10.1186/s12886-019-1074-5.
10
Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokeratoconjunctivitis in Children.结膜下注射曲安奈德和贝伐单抗联合治疗儿童睑角膜结膜炎
Case Rep Ophthalmol Med. 2018 Jun 5;2018:2602487. doi: 10.1155/2018/2602487. eCollection 2018.

本文引用的文献

1
A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction.一项评估ω-3 脂肪酸补充剂对睑板腺功能障碍影响的随机、双盲研究。
Clin Interv Aging. 2013;8:1133-8. doi: 10.2147/CIA.S48955. Epub 2013 Aug 30.
2
Anti-inflammatory effects of alpha linolenic acid on human corneal epithelial cells.α-亚麻酸对人眼角膜上皮细胞的抗炎作用。
Invest Ophthalmol Vis Sci. 2012 Jul 3;53(8):4396-406. doi: 10.1167/iovs.12-9724.
3
Interventions for chronic blepharitis.慢性睑缘炎的干预措施。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD005556. doi: 10.1002/14651858.CD005556.pub2.
4
Childhood blepharokeratoconjunctivitis: characterising a severe phenotype in white adolescents.儿童型睑裂部角膜结膜炎:白人青少年中一种严重表型的特征。
Br J Ophthalmol. 2012 Jul;96(7):949-55. doi: 10.1136/bjophthalmol-2011-300771. Epub 2012 Apr 13.
5
Severity of pediatric blepharokeratoconjunctivitis in Asian eyes.亚洲人儿童眼脸-角膜-结膜炎的严重程度。
Am J Ophthalmol. 2012 Mar;153(3):564-570.e1. doi: 10.1016/j.ajo.2011.08.037. Epub 2011 Nov 8.
6
Amblyopia.弱视
BMJ Clin Evid. 2011 Jun 30;2011:0709.
7
Nutritional supplements for dry eye syndrome.干眼症的营养补充剂。
Curr Opin Ophthalmol. 2011 Jul;22(4):279-82. doi: 10.1097/ICU.0b013e3283477d23.
8
The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction.睑板腺功能障碍国际研讨会:睑板腺功能障碍管理与治疗小组委员会报告
Invest Ophthalmol Vis Sci. 2011 Mar 30;52(4):2050-64. doi: 10.1167/iovs.10-6997g.
9
Clinical spectrum of pediatric blepharokeratoconjunctivitis.小儿睑缘角膜结膜炎的临床谱
J AAPOS. 2010 Dec;14(6):527-9. doi: 10.1016/j.jaapos.2010.09.013. Epub 2010 Nov 19.
10
Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye.一项关于ω-3 补充剂治疗干眼症的前瞻性、随机、双盲、安慰剂对照临床试验。
Cornea. 2011 Mar;30(3):308-14. doi: 10.1097/ICO.0b013e3181f22e03.

儿童睑角膜结膜炎:角膜受累情况及视力预后

Blepharokeratoconjunctivitis in childhood: corneal involvement and visual outcome.

作者信息

Rodríguez-García A, González-Godínez S, López-Rubio S

机构信息

Cornea and Ocular Surface Service, Ophthalmology and Visual Sciences Institute, School of Medicine, Tecnológico de Monterrey, Monterrey, Mexico.

Ophthalmology and Visual Sciences Institute, School of Medicine, Tecnológico de Monterrey, Monterrey, Mexico.

出版信息

Eye (Lond). 2016 Mar;30(3):438-46. doi: 10.1038/eye.2015.249. Epub 2015 Dec 4.

DOI:10.1038/eye.2015.249
PMID:26634709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4791702/
Abstract

PURPOSE

The main objective of this study is to describe the prevalence, degree and risk of corneal involvement, and visual impact in a pediatric population with blepharokeratoconjunctivitis (BKC).

METHODS

Retrospective, observational, case-control study. Clinical records of patients ≤16 years old with BKC seen between 2006 and 2012 were reviewed. The prevalence and relative risk of corneal involvement was evaluated between patients with and without corneal affection through a univariate and multivariate analysis with logistic regression. Visual acuity at presentation and at last follow-up visit was also analyzed.

RESULTS

One hundred and fourteen children with BKC, with a male-to-female ratio of 1 : 1 and a mean age at diagnosis of 9.13 years. The mean follow-up time was 26.4 (±25) months. Corneal involvement was present in 39.5% of patients, varying from superficial punctate keratitis to perforation. Corneal changes were not seen in children under 4 years old. The risk of corneal affection was greater in patients with photophobia, hordeolum, female gender and asymmetric disease (OR of 2.69, 11.6, 2.35 and 2.77, respectively). The mean best-corrected visual acuity at presentation was 0.20 (corneal affected group), compared to 0.11 (unaffected group; P=0.02).

CONCLUSIONS

Our study showed an older age at time of diagnosis and a worse visual outcome in patients with BKC and corneal disease compared with previous reports. Early diagnosis and detection of risk factors for corneal involvement, as well as adequate treatment, is mandatory to prevent serious long-term visual repercussions in children with BKC.

摘要

目的

本研究的主要目的是描述患有睑角膜结膜炎(BKC)的儿科人群中角膜受累的患病率、程度和风险以及视觉影响。

方法

回顾性、观察性病例对照研究。对2006年至2012年间就诊的年龄≤16岁的BKC患者的临床记录进行了回顾。通过单因素和多因素逻辑回归分析,评估有角膜病变和无角膜病变患者之间角膜受累的患病率和相对风险。还分析了初诊时和最后一次随访时的视力。

结果

114例BKC患儿,男女比例为1∶1,诊断时平均年龄为9.13岁。平均随访时间为26.4(±25)个月。39.5%的患者存在角膜受累,从浅层点状角膜炎到穿孔不等。4岁以下儿童未见角膜变化。畏光、睑腺炎、女性和不对称疾病患者发生角膜病变的风险更高(比值比分别为2.69、11.6、2.35和2.77)。初诊时平均最佳矫正视力在角膜受累组为0.20,而在未受累组为0.11(P = 0.02)。

结论

我们的研究表明,与先前的报告相比,BKC和角膜疾病患者的诊断年龄更大,视觉预后更差。早期诊断和发现角膜受累的危险因素以及适当治疗对于预防BKC患儿严重的长期视觉影响至关重要。